Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib extension study in solid tumors
NCT02033551Phase 1Completed
- Sponsor
- AbbVie Inc.
- Start
- Dec 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 1, open-label trial of veliparib in solid tumor (3 arms), sponsored by AbbVie Inc. Primary endpoint: Number of subjects with adverse events. Started Dec 2013; status: completed.
02
Drugs
veliparib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02033551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033551.